The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment

2018 ◽  
Vol 59 (3) ◽  
pp. 383-393 ◽  
Author(s):  
Stephen D. Silberstein ◽  
Alan M. Rapoport ◽  
Pippa S. Loupe ◽  
Ernesto Aycardi ◽  
Mirna McDonald ◽  
...  
Keyword(s):  
High Frequency ◽  
Episodic Migraine ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Associated Symptoms ◽  
Post Hoc ◽  
Randomized Phase 2

scholarly journals Intra-articular CNTX-4975 for osteoarthritis knee pain: subgroup and post hoc analyses of a randomized phase 2 study

2019 ◽  
Vol 27 ◽  
pp. S499
Author(s):  
R.M. Stevens ◽  
J.N. Campbell ◽  
K. Guedes ◽  
V.H. Smith ◽  
P.D. Hanson ◽  
...  
Keyword(s):  
Knee Pain ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Osteoarthritis Knee ◽  
Post Hoc ◽  
Randomized Phase 2

scholarly journals A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults

2019 ◽  
Vol 59 (10) ◽  
pp. 1731-1742 ◽  
Author(s):  
Fumihiko Sakai ◽  
Takao Takeshima ◽  
Yoshihisa Tatsuoka ◽  
Koichi Hirata ◽  
Robert Lenz ◽  
...  
Keyword(s):  
Episodic Migraine ◽  
Phase 2 ◽  
Japanese Adults ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

Nature Aging ◽  
2021 ◽  
Vol 1 (6) ◽  
pp. 521-534
Author(s):  
Petr Novak ◽  
Branislav Kovacech ◽  
Stanislav Katina ◽  
Reinhold Schmidt ◽  
Philip Scheltens ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Active Immunotherapy ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document